var data={"title":"Treatment protocols for squamous cell carcinoma of the head and neck","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Treatment protocols for squamous cell carcinoma of the head and neck</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributors\" class=\"contributor contributor_credentials\">Tim Brenner, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributors\" class=\"contributor contributor_credentials\">Shrina Duggal, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributors\" class=\"contributor contributor_credentials\">Jim Natale, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributors\" class=\"contributor contributor_credentials\">Scott M Wirth, PharmD, BCOP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributors\" class=\"contributor contributor_credentials\">John W Mucenski, PharmD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributors\" class=\"contributor contributor_credentials\">Michael E Ross, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-squamous-cell-carcinoma-of-the-head-and-neck/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 13, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H6926729\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with squamous cell carcinoma of the head and neck. <strong>This is</strong> <strong>not an exhaustive list</strong>; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with squamous cell carcinoma of the head and neck. Additional regimens may be added over time, particularly as treatment for squamous cell carcinoma of the head and neck evolves.</p><p>This topic review is intended to provide only a listing of chemotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with squamous cell carcinoma of the head and neck. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-approaches-combining-chemotherapy-and-radiation-therapy\" class=\"medical medical_review\">&quot;Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=treatment-of-metastatic-and-recurrent-head-and-neck-cancer\" class=\"medical medical_review\">&quot;Treatment of metastatic and recurrent head and neck cancer&quot;</a>.)</p><p/><p>These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.</p><p class=\"headingAnchor\" id=\"H120499976\"><span class=\"h1\">REGIMENS</span></p><p class=\"headingAnchor\" id=\"H1560463784\"><span class=\"h2\">Docetaxel, cisplatin, fluorouracil (TAX324)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F65438\" class=\"graphic graphic_table graphicRef65438 \">table 1</a>)</p><p class=\"headingAnchor\" id=\"H1560463797\"><span class=\"h2\">Docetaxel, cisplatin, fluorouracil (TAX323)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F72461\" class=\"graphic graphic_table graphicRef72461 \">table 2</a>)</p><p class=\"headingAnchor\" id=\"H937049771\"><span class=\"h2\">Cetuximab</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F56253\" class=\"graphic graphic_table graphicRef56253 \">table 3</a>)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 85694 Version 7.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H6926729\" id=\"outline-link-H6926729\">INTRODUCTION</a></li><li><a href=\"#H120499976\" id=\"outline-link-H120499976\">REGIMENS</a><ul><li><a href=\"#H1560463784\" id=\"outline-link-H1560463784\">Docetaxel, cisplatin, fluorouracil (TAX324)</a></li><li><a href=\"#H1560463797\" id=\"outline-link-H1560463797\">Docetaxel, cisplatin, fluorouracil (TAX323)</a></li><li><a href=\"#H937049771\" id=\"outline-link-H937049771\">Cetuximab</a></li></ul></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ONC/85694|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ONC/65438\" class=\"graphic graphic_table\">- Docetaxel cisplatin and FU plus chemoRT HNC ver1</a></li><li><a href=\"image.htm?imageKey=ONC/72461\" class=\"graphic graphic_table\">- Docetaxel cisplatin and FU plus RT HNC ver2</a></li><li><a href=\"image.htm?imageKey=ONC/56253\" class=\"graphic graphic_table\">- Cetuximab for recurrent and-or metastatic head and neck cancer</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-approaches-combining-chemotherapy-and-radiation-therapy\" class=\"medical medical_review\">Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-metastatic-and-recurrent-head-and-neck-cancer\" class=\"medical medical_review\">Treatment of metastatic and recurrent head and neck cancer</a></li></ul></div></div>","javascript":null}